GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (OTCPK:MBCOF) » Definitions » Other Stockholders Equity

MBCOF (Marvel Biosciences) Other Stockholders Equity : $-0.00 Mil (As of Oct. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Marvel Biosciences Other Stockholders Equity?

Marvel Biosciences's Other Stockholders Equity for the quarter that ended in Oct. 2024 was $-0.00 Mil.

Marvel Biosciences's quarterly Other Stockholders Equity stayed the same from Apr. 2024 ($0.00 Mil) to Jul. 2024 ($0.00 Mil) but then declined from Jul. 2024 ($0.00 Mil) to Oct. 2024 ($-0.00 Mil).

Marvel Biosciences's annual Other Stockholders Equity increased from Jul. 2022 ($-0.02 Mil) to Jul. 2023 ($0.00 Mil) but then declined from Jul. 2023 ($0.00 Mil) to Jul. 2024 ($0.00 Mil).


Marvel Biosciences Other Stockholders Equity Historical Data

The historical data trend for Marvel Biosciences's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marvel Biosciences Other Stockholders Equity Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24
Other Stockholders Equity
- - -0.02 - -

Marvel Biosciences Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Marvel Biosciences Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Marvel Biosciences Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Marvel Biosciences's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Marvel Biosciences Business Description

Traded in Other Exchanges
Address
505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.